Trials / Completed
CompletedNCT01284218
Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23,514 (actual)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To examine the differences in health care utilization and costs between MDD patients on adjunctive aripiprazole therapy and MDD patients on other augmentation therapies.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-01-26
- Last updated
- 2013-11-08
Source: ClinicalTrials.gov record NCT01284218. Inclusion in this directory is not an endorsement.